AVROBIO, Inc. Reports Fourth Quarter and Fiscal Year 2018 Financial Results and Provides Business Update
Recruitment completed in investigator-sponsored Phase 1 Fabry study Phase 1 and Phase 2 clinical data updates for AVR-RD-01 in Fabry…
Pharmaceuticals, Biotechnology and Life Sciences
Recruitment completed in investigator-sponsored Phase 1 Fabry study Phase 1 and Phase 2 clinical data updates for AVR-RD-01 in Fabry…
Urges Shareholders to Vote “FOR” the Proposed Transaction on the WHITE Proxy Card NEW YORK–(BUSINESS WIRE)–Bristol-Myers Squibb Company’s (NYSE:BMY) Board…
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies…
DUBLIN–(BUSINESS WIRE)–The “Animal Biotechnology – Technologies, Markets and Companies” report from Jain PharmaBiotech has been added to ResearchAndMarkets.com’s offering. This…
CHENGDU, China–(BUSINESS WIRE)–HitGen Ltd announced that the company has entered into a research collaboration with Almirall to identify novel small…
Funding in excess of US$1 million to support the development of a brain imaging probe for patient diagnosis and the…
CAMBRIDGE, Mass.–(BUSINESS WIRE)—-Axcella Health, a biotechnology company pioneering the research and development of novel multifactorial interventions to address dysregulated metabolism…
The study was presented at ENDO 2019, Endocrine Society’s annual meeting DUARTE, Calif.–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/CityofHope?src=hash” target=”_blank”gt;#CityofHopelt;/agt;–The hemoglobin A1c blood test…
SAN DIEGO–(BUSINESS WIRE)–Gossamer Bio, Inc. (Nasdaq:GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the…
JERUSALEM–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the launch of a generic version of EXJADE®1 (deferasirox)…